Evidence map›Paper›PMID 29379761›Full record

ArticleSchizophrenia research. Cognition2015

Neurocognition as a predictor of outcome in schizophrenia in the Northern Finland Birth Cohort 1966.

P Juola, J Miettunen, H Salo, G K Murray, A O Ahmed, J Veijola, M Isohanni, E Jääskeläinen

Abstract read
In one paragraph

Article in Schizophrenia research. Cognition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

P JuolaResearch Unit of Clinical Neuroscience, Department of Psychiatry, University of Oulu, P.O. BOX 5000, FIN-90014, Finland.
J MiettunenResearch Unit of Clinical Neuroscience, Department of Psychiatry, University of Oulu, P.O. BOX 5000, FIN-90014, Finland.
H SaloResearch Unit of Clinical Neuroscience, Department of Psychiatry, University of Oulu, P.O. BOX 5000, FIN-90014, Finland.
G K MurrayUniversity of Cambridge, Department of Psychiatry, Box 189 Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom.
A O AhmedDepartment of Psychiatry and Health Behavior, Medical College of Georgia, Georgia Regents University; 997 Saint Sebastian Way, Augusta, GA 30912, USA.
J VeijolaResearch Unit of Clinical Neuroscience, Department of Psychiatry, University of Oulu, P.O. BOX 5000, FIN-90014, Finland.
M IsohanniResearch Unit of Clinical Neuroscience, Department of Psychiatry, University of Oulu, P.O. BOX 5000, FIN-90014, Finland.
E JääskeläinenResearch Unit of Clinical Neuroscience, Department of Psychiatry, University of Oulu, P.O. BOX 5000, FIN-90014, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to study neurocognitive performance as a predictor of outcomes in midlife schizophrenia. There is a lack of studies with unselected samples and a long follow-up. The study is based on the prospective, unselected population-based Northern Finland Birth Cohort 1966. The study includes 43 individuals with schizophrenia and 73 controls, whose neurocognitive performance was assessed twice, at 34 and 43 years. At both time points we used identical neurocognitive tests to assess verbal and visual memory and executive functions. Our main aim was to analyse neurocognitive performance at 34 years as a predictor of clinical, vocational and global outcomes at 43 years. Additionally, the analysis addressed cross-sectional associations between cognitive performance and clinical, vocational and global measures at 43 years. The assessment of outcomes was performed in the schizophrenia group only. In the longitudinal analysis poorer visual memory predicted poorer vocational outcome and poorer long-term verbal memory predicted poorer global outcome. In the cross-sectional analysis poorer visual memory and lower composite score of neurocognition were associated with poorer global outcome. No individual neurocognitive test or the composite score of these predicted remission. These data indicate that neurocognition, especially memory function, is an important determinant of long-term functional outcome in midlife schizophrenia.

Indexed as

LongitudinalNeurocognitionOutcomePopulation-basedPredictionSchizophrenia

Identifiers

PMID29379761
PMCPMC5779303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.